BMP1-like proteinases are essential to the structure and wound healing of skin

Matrix Biology

Volumn 56, Issue , 2016, Pages 114-131

  Muir, Alison M ^a   Massoudi, Dawiyat ^a   Nguyen, Ngon ^b,c   Keene, Douglas R ^d   Lee, Se Jin ^e   Birk, David E ^f   Davidson, Jeffrey M ^g,h   Marinkovich, M Peter ^b,c   Greenspan, Daniel S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d SHRINERS HOSPITAL FOR CHILDREN   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biglycan; Bone morphogenetic protein 1 (BMP1) mammalian tolloid like 1; Collagen; Decorin; Skin; Wound healing

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 7; DECORIN; FIBRILLAR COLLAGEN; KALININ; MONOMER; PROCOLLAGEN C PROTEINASE; RNA; TAMOXIFEN; TOLLOID METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; BGN PROTEIN, MOUSE; BMP1 PROTEIN, MOUSE; DCN PROTEIN, MOUSE; TLL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; COLLAGEN FIBRIL; COMPARATIVE STUDY; CONTROLLED STUDY; DERMIS; ENZYME ACTIVITY; EPITHELIZATION; GENOTYPE; HISTOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MYOFIBROBLAST; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOMALACIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN BIOPSY; SKIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANIMAL; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENE KNOCKOUT; GENETICS; MALE; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 1; CELLS, CULTURED; DECORIN; DERMIS; GENE KNOCKOUT TECHNIQUES; MALE; MICE, TRANSGENIC; RE-EPITHELIALIZATION; TOLLOID-LIKE METALLOPROTEINASES;

EID: 85000460233     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.06.004     Document Type: Article

References (63)

1. [1] Muir, A., Greenspan, D.S., Metalloproteinases in Drosophila to humans that are central players in developmental processes. J. Biol. Chem. 286:49 (2011), 41905–41911.
2. [2] Kessler, E., Takahara, K., Biniaminov, L., Brusel, M., Greenspan, D.S., Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 271:5247 (1996), 360–362.
3. [3] Hopkins, D.R., Keles, S., Greenspan, D.S., The bone morphogenetic protein 1/tolloid-like metalloproteinases. Matrix Biol. 26:7 (2007), 508–523.
4. [4] Vadon-Le Goff, S., Hulmes, D.J., Moali, C., BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol. 44-46 (2015), 14–23.
5. [5] Uzel, M.I., Scott, I.C., Babakhanlou-Chase, H., Palamakumbura, A.H., Pappano, W.N., Hong, H.H., Greenspan, D.S., Trackman, P.C., Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J. Biol. Chem. 276:25 (2001), 22537–22543.
6. [6] Scott, I.C., Imamura, Y., Pappano, W.N., Troedel, J.M., Recklies, A.D., Roughley, P.J., Greenspan, D.S., Bone morphogenetic protein-1 processes probiglycan. J. Biol. Chem. 275:39 (2000), 30504–30511.
7. [7] Unsold, C., Pappano, W.N., Imamura, Y., Steiglitz, B.M., Greenspan, D.S., Biosynthetic processing of the pro-alpha 1(V)2pro-alpha 2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases. J. Biol. Chem. 277:7 (2002), 5596–5602.
8. [8] von Marschall, Z., Fisher, L.W., Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1). Biochem. Biophys. Res. Commun. 391:3 (2010), 1374–1378.
9. [9] Pappano, W.N., Steiglitz, B.M., Scott, I.C., Keene, D.R., Greenspan, D.S., Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. Mol. Cell. Biol. 23:13 (2003), 4428–4438.
10. [10] Birk, D.E., Fitch, J.M., Babiarz, J.P., Doane, K.J., Linsenmayer, T.F., Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J. Cell Sci. 95:Pt 4 (1990), 649–657.
11. [11] Mendler, M., Eich-Bender, S.G., Vaughan, L., Winterhalter, K.H., Bruckner, P., Cartilage contains mixed fibrils of collagen types II, IX, and XI. J. Cell Biol. 108:1 (1989), 191–197.
12. [12] Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., Iozzo, R.V., Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:3 (1997), 729–743.
13. [13] Corsi, A., Xu, T., Chen, X.D., Boyde, A., Liang, J., Mankani, M., Sommer, B., Iozzo, R.V., Eichstetter, I., Robey, P.G., Bianco, P., Young, M.F., Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17:7 (2002), 1180–1189.
14. [14] Rattenholl, A., Pappano, W.N., Koch, M., Keene, D.R., Kadler, K.E., Sasaki, T., Timpl, R., Burgeson, R.E., Greenspan, D.S., Bruckner-Tuderman, L., Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J. Biol. Chem. 277:29 (2002), 26372–26378.
15. [15] Amano, S., Scott, I.C., Takahara, K., Koch, M., Champliaud, M.F., Gerecke, D.R., Keene, D.R., Hudson, D.L., Nishiyama, T., Lee, S., Greenspan, D.S., Burgeson, R.E., Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J. Biol. Chem. 275:30 (2000), 22728–22735.
16. [16] Veitch, D.P., Nokelainen, P., McGowan, K.A., Nguyen, T.T., Nguyen, N.E., Stephenson, R., Pappano, W.N., Keene, D.R., Spong, S.M., Greenspan, D.S., Findell, P.R., Marinkovich, M.P., Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J. Biol. Chem. 278:18 (2003), 15661–15668.
17. [17] Ge, G., Greenspan, D.S., BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J. Cell Biol. 175:1 (2006), 111–120.
18. [18] Piccolo, S., Agius, E., Lu, B., Goodman, S., Dale, L., De Robertis, E.M., Cleavage of chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91:3 (1997), 407–416.
19. [19] Blader, P., Rastegar, S., Fischer, N., Strahle, U., Cleavage of the BMP-4 antagonist chordin by zebrafish tolloid. Science 278:5345 (1997), 1937–1940.
20. [20] Scott, I.C., Blitz, I.L., Pappano, W.N., Imamura, Y., Clark, T.G., Steiglitz, B.M., Thomas, C.L., Maas, S.A., Takahara, K., Cho, K.W., Greenspan, D.S., Mammalian BMP-1/tolloid-related metalloproteinases, including novel family member mammalian tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis. Dev. Biol. 213:2 (1999), 283–300.
21. [21] Jasuja, R., Voss, N., Ge, G., Hoffman, G.G., Lyman-Gingerich, J., Pelegri, F., Greenspan, D.S., Bmp1 and mini fin are functionally redundant in regulating formation of the zebrafish dorsoventral axis. Mech. Dev. 123:7 (2006), 548–558.
22. [22] Massague, J., The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6 (1990), 597–641.
23. [23] Suzuki, N., Labosky, P.A., Furuta, Y., Hargett, L., Dunn, R., Fogo, A.B., Takahara, K., Peters, D.M., Greenspan, D.S., Hogan, B.L., Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development 122:11 (1996), 3587–3595.
24. [24] Clark, T.G., Conway, S.J., Scott, I.C., Labosky, P.A., Winnier, G., Bundy, J., Hogan, B.L., Greenspan, D.S., The mammalian tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. Development 126:12 (1999), 2631–2642.
25. [25] Takahara, K., Lyons, G.E., Greenspan, D.S., Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues. J. Biol. Chem. 269:51 (1994), 32572–32578.
26. [26] Takahara, K., Brevard, R., Hoffman, G.G., Suzuki, N., Greenspan, D.S., Characterization of a novel gene product (mammalian tolloid-like) with high sequence similarity to mammalian tolloid/bone morphogenetic protein-1. Genomics 34:2 (1996), 157–165.
27. [27] Lee, S.J., Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One, 3(2), 2008, e1628.
28. [28] Muir, A.M., Ren, Y., Butz, D.H., Davis, N.A., Blank, R.D., Birk, D.E., Lee, S.J., Rowe, D., Feng, J.Q., Greenspan, D.S., Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. Hum. Mol. Genet. 23:12 (2014), 3085–3101.
29. [29] Feng, J.Q., Ward, L.M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S.I., Zhang, S., Rios, H., Drezner, M.K., Quarles, L.D., Bonewald, L.F., White, K.E., Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38:11 (2006), 1310–1315.
30. [30] Syx, D., Guillemyn, B., Symoens, S., Sousa, A.B., Medeira, A., Whiteford, M., Hermanns-Le, T., Coucke, P.J., De Paepe, A., Malfait, F., Defective proteolytic processing of fibrillar procollagens and prodecorin due to biallelic bmp1 mutations results in a severe, progressive form of osteogenesis imperfecta. J Bone Miner Res, 2015.
31. [31] Fahiminiya, S., Al-Jallad, H., Majewski, J., Palomo, T., Moffatt, P., Roschger, P., Klaushofer, K., Glorieux, F.H., Rauch, F., A polyadenylation site variant causes transcript-specific BMP1 deficiency and frequent fractures in children. Hum. Mol. Genet. 24:2 (2015), 516–524.
32. [32] Cho, S.Y., Asharani, P.V., Kim, O.H., Iida, A., Miyake, N., Matsumoto, N., Nishimura, G., Ki, C.S., Hong, G., Kim, S.J., Sohn, Y.B., Park, S.W., Lee, J., Kwun, Y., Carney, T.J., Huh, R., Ikegawa, S., Jin, D.K., Identification and in vivo functional characterization of novel compound heterozygous BMP1 variants in osteogenesis imperfecta. Hum. Mutat. 36:2 (2015), 191–195.
33. [33] Valencia, M., Caparros-Martin, J.A., Sirerol-Piquer, M.S., Garcia-Verdugo, J.M., Martinez-Glez, V., Lapunzina, P., Temtamy, S., Aglan, M., Lund, A.M., Nikkels, P.G., Ruiz-Perez, V.L., Ostergaard, E., Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects. Am. J. Med. Genet. A 164A:5 (2014), 1143–1150.
34. [34] Asharani, P.V., Keupp, K., Semler, O., Wang, W., Li, Y., Thiele, H., Yigit, G., Pohl, E., Becker, J., Frommolt, P., Sonntag, C., Altmuller, J., Zimmermann, K., Greenspan, D.S., Akarsu, N.A., Netzer, C., Schonau, E., Wirth, R., Hammerschmidt, M., Nurnberg, P., Wollnik, B., Carney, T.J., Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am. J. Hum. Genet. 90:4 (2012), 661–674.
35. [35] Martinez-Glez, V., Valencia, M., Caparros-Martin, J.A., Aglan, M., Temtamy, S., Tenorio, J., Pulido, V., Lindert, U., Rohrbach, M., Eyre, D., Giunta, C., Lapunzina, P., Ruiz-Perez, V.L., Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum. Mutat. 33:2 (2012), 343–350.
36. [36] Yamaguchi, Y., Mann, D.M., Ruoslahti, E., Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:6281 (1990), 281–284.
37. [37] Darby, I.A., Laverdet, B., Bonte, F., Desmouliere, A., Fibroblasts and myofibroblasts in wound healing. Clin. Cosmet. Investig. Dermatol. 7 (2014), 301–311.
38. [38] Darby, I., Skalli, O., Gabbiani, G., Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Investig. 63:1 (1990), 21–29.
39. [39] Sakai, L.Y., Keene, D.R., Morris, N.P., Burgeson, R.E., Type VII collagen is a major structural component of anchoring fibrils. J. Cell Biol. 103:4 (1986), 1577–1586.
40. [40] Lunstrum, G.P., Kuo, H.J., Rosenbaum, L.M., Keene, D.R., Glanville, R.W., Sakai, L.Y., Burgeson, R.E., Anchoring fibrils contain the carboxyl-terminal globular domain of type VII procollagen, but lack the amino-terminal globular domain. J. Biol. Chem. 262:28 (1987), 13706–13712.
41. [41] Morris, N.P., Keene, D.R., Glanville, R.W., Bentz, H., Burgeson, R.E., The tissue form of type VII collagen is an antiparallel dimer. J. Biol. Chem. 261:12 (1986), 5638–5644.
42. [42] Bruckner-Tuderman, L., Nilssen, O., Zimmermann, D.R., Dours-Zimmermann, M.T., Kalinke, D.U., Gedde-Dahl, T. Jr., Winberg, J.O., Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J. Cell Biol. 131:2 (1995), 551–559.
43. [43] Muir, A.M., Ren, Y., Butz, D.H., Davis, N.A., Blank, R.D., Birk, D.E., Lee, S.J., Rowe, D., Feng, J.Q., Greenspan, D.S., Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. Hum. Mol. Genet., 2014, 3085–3101.
44. [44] Steiglitz, B.M., Kreider, J.M., Frankenburg, E.P., Pappano, W.N., Hoffman, G.G., Meganck, J.A., Liang, X., Hook, M., Birk, D.E., Goldstein, S.A., Greenspan, D.S., Procollagen C proteinase enhancer 1 genes are important determinants of the mechanical properties and geometry of bone and the ultrastructure of connective tissues. Mol. Cell. Biol. 26:1 (2006), 238–249.
45. [45] Prockop, H.D. DJ, Assembly of collagen fibrils de novo from soluble precursors: polymerization and copolymerization of procollagen, pN-collagen, and mutated collgens. Yurchenco, P.D., Birk, D.E., Mechan, R.P., (eds.) Extracellular Matrix Assembly and Structure, 1994, Academic Press, New York, 47–90.
46. [46] Prox, J., Arnold, P., Becker-Pauly, C., Meprin alpha and meprin beta: procollagen proteinases in health and disease. Matrix Biol. 44-46 (2015), 7–13.
47. [47] Sterchi, E.E., Stocker, W., Bond, J.S., Meprins, membrane-bound and secreted astacin metalloproteinases. Mol. Asp. Med. 29:5 (2008), 309–328.
48. [48] Li, Y., Liu, Y., Xia, W., Lei, D., Voorhees, J.J., Fisher, G.J., Age-dependent alterations of decorin glycosaminoglycans in human skin. Sci. Rep., 3, 2013, 2422.
49. [49] Bianco, P., Fisher, L.W., Young, M.F., Termine, J.D., Robey, P.G., Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38:11 (1990), 1549–1563.
50. [50] Steijlen, P.M., Maessen, E., Kresse, H., Van Vlijmen, I.M., Verstraeten, A.A., Traupe, H., Schalkwijk, J., Expression of tenascin, biglycan and decorin in disorders of keratinization. Br. J. Dermatol. 130:5 (1994), 564–568.
51. [51] Hunzelmann, N., Schonherr, E., Bonnekoh, B., Hartmann, C., Kresse, H., Krieg, T., Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J. Invest. Dermatol. 104:4 (1995), 509–513.
52. [52] Lee, S., Solow-Cordero, D.E., Kessler, E., Takahara, K., Greenspan, D.S., Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J. Biol. Chem. 272:30 (1997), 19059–19066.
53. [53] Annes, J.P., Munger, J.S., Rifkin, D.B., Making sense of latent TGFbeta activation. J. Cell Sci. 116:Pt 2 (2003), 217–224.
54. [54] Ge, G., Seo, N.S., Liang, X., Hopkins, D.R., Hook, M., Greenspan, D.S., Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J. Biol. Chem. 279:40 (2004), 41626–41633.
55. [55] Delolme, F., Anastasi, C., Alcaraz, L.B., Mendoza, V., Vadon-Le Goff, S., Talantikite, M., Capomaccio, R., Mevaere, J., Fortin, L., Mazzocut, D., Damour, O., Zanella-Cleon, I., Hulmes, D.J., Overall, C.M., Valcourt, U., Lopez-Casillas, F., Moali, C., Proteolytic control of TGF-beta co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics. Cell. Mol. Life Sci. 72:5 (2015), 1009–1027.
56. [56] Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V., Kehrl, J.H., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U. S. A. 83:12 (1986), 4167–4171.
57. [57] Rousselle, P., Beck, K., Laminin 332 processing impacts cellular behavior. Cell Adhes. Migr. 7:1 (2013), 122–134.
58. [58] Dunn, L., Prosser, H.C., Tan, J.T., Vanags, L.Z., Ng, M.K., Bursill, C.A., Murine model of wound healing. J. Vis. Exp.(75), 2013, e50265.
59. [59] Marinkovich, M.P., Lunstrum, G.P., Burgeson, R.E., The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J. Biol. Chem. 267:25 (1992), 17900–17906.
60. [60] Fisher, L.W., Stubbs, J.T. 3rd, Young, M.F., Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. Suppl. 266 (1995), 61–65.
61. [61] Kuhl, T., Mezger, M., Hausser, I., Handgretinger, R., Bruckner-Tuderman, L., Nystrom, A., High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa. Mol. Ther. 23:8 (2015), 1368–1379.
62. [62] Keene, D.R., Sakai, L.Y., Lunstrum, G.P., Morris, N.P., Burgeson, R.E., Type VII collagen forms an extended network of anchoring fibrils. J. Cell Biol. 104:3 (1987), 611–621.
63. [63] Siprashvili, Z., Nguyen, N.T., Bezchinsky, M.Y., Marinkovich, M.P., Lane, A.T., Khavari, P.A., Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum. Gene Ther. 21:10 (2010), 1299–1310.